Moore Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,000
| Closed | -$2.44M | – | 507 |
|
|
2025
Q1 | $2.44M | Sell |
10,000
-35,000
| -78% | -$8.52M | 0.05% | 205 |
|
|
2024
Q4 | $14.8M | Hold |
45,000
| – | – | 0.17% | 86 |
|
|
2024
Q3 | $15.1M | Buy |
+45,000
| New | +$15.1M | 0.28% | 75 |
|
|
2023
Q4 | – | Sell |
-12,500
| Closed | -$4.48M | – | 412 |
|
|
2023
Q3 | $4.48M | Sell |
12,500
-12,500
| -50% | -$4.48M | 0.08% | 140 |
|
|
2023
Q2 | $9.48M | Buy |
25,000
+23,900
| +2,173% | +$9.06M | 0.16% | 89 |
|
|
2023
Q1 | $527K | Buy |
+1,100
| New | +$527K | 0.01% | 286 |
|